CD68 and amyotrophic lateral sclerosis: Quantification of the results revealed an increase of CD68-positive cells in spinal cord sections of ALS-CSF-treated group (Figure 4G,H) which was corroborated with an increase of CD68 levels by immunoblotting of spinal cord lysates (Figure 4J).